Efficacy of initial combination therapy with anti-SARS-CoV-2 antivirals targeting viral clearance in COVID-19 patients with B-cell lymphoma treated with anti-CD20 antibodies: A retrospective single-centre study in Japan
This study showed the potential of early combination antiviral therapy to shorten the time to viral clearance in this high-risk patient population.
Authors
- Yasuyuki Kuwagata (ORCID: https://orcid.org/0000-0002-2344-8604)
- Masami Kashihara
- Kazuyoshi Ishii
- Akira Inoue (ORCID: https://orcid.org/0000-0002-5000-9084)
- Fukuki Saito
- Yasushi Nakamori
- Daiki Wada (ORCID: https://orcid.org/0000-0002-3404-9924)
- Junya Shimazaki (ORCID: https://orcid.org/0000-0003-3004-3127)
- Shuhei Maruyama (ORCID: https://orcid.org/0009-0009-9836-2870)
Institutions
- Kansai Medical University (JP)
Publication Details
- Journal
- Journal of Infection and Chemotherapy
- Published
- 2025-05-08
- DOI
- https://doi.org/10.1016/j.jiac.2025.102726
- Citations
- 3
- Primary Topic
- COVID-19 and healthcare impacts
- Type
- article
- Field-Weighted Citation Impact
- 3.14